Abstract

BackgroundB7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are important regulators of T cell activation. We investigated the role of the B7 family of costimulatory molecules in the development of the systemic maternal immune tolerance during healthy pregnancy (HP). We also aimed to investigate the intracellular expression of indoleamine-2,3-dioxygenase (IDO) and plasma levels of tryptophane (TRP), kynurenine (KYN) and kynurenic acid (KYNA), important molecules with immunoregulatory properties, in order to describe their potential contribution to the pregnancy-specific maternal immune tolerance.MethodsWe determined the frequency of activated (CD11b+) monocytes expressing B7-1, B7-2, B7-H1, and B7-H2, and that of T cells and CD4+ T helper cells expressing CD28, CTLA-4, PD-1, and ICOS in peripheral blood samples of healthy pregnant (HP) and non-pregnant (NP) women using flow cytometry. We also examined the intracellular expression of IDO applying flow cytometry and plasma levels of TRP, KYN and KYNA using high-performance liquid chromatography.ResultsA significant increase in the prevalence of CD28+ T cells was observed in HP compared to NP women. At the same time a decrease was shown in the expression of CTLA-4 on these cells. The frequency of CD80+ monocytes was lower in HP women. The prevalence of IDO-expressing T cells and monocytes was higher in HP compared to NP women. Plasma KYN, KYNA and TRP levels were lower, while at the same time, the KYN/TRP ratio was higher in HP than in NP women.ConclusionsCostimulation via CD28 may not contribute to the immunosuppressive environment, at least in the third trimester of pregnancy. The development of the pregnancy-specific immune tolerance in the mechanism of B7 costimulation may be more related to the altered expression of B7 proteins on APCs rather than that of their receptors on T cells. The elevated intracellular IDO expression in monocytes and T cells, as well as higher plasma enzymatic IDO activity are likely to contribute to the systemic immunosuppressive environment in the third trimester characteristic for healthy gestation.Electronic supplementary materialThe online version of this article (doi:10.1186/1471-2393-14-306) contains supplementary material, which is available to authorized users.

Highlights

  • B7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are important regulators of T cell activation

  • We aimed to determine the frequency of activated monocytes expressing B7-1, B7-2, B7-H1 and B7H2 costimulatory molecules, as well as that of T cells and T helper cells expressing CD28, Cytotoxic T lymphocyte antigen 4 (CTLA-4), Programmed death-1 receptor (PD-1) and Inducible costimulator of T cells (ICOS) in peripheral blood samples of healthy pregnancy (HP) compared to nonpregnant (NP) women

  • A significant increase in the prevalence of CD28+ T cells was observed in HP compared to NP women

Read more

Summary

Introduction

B7 costimulatory molecules are expressed on antigen presenting cells (APCs) and are important regulators of T cell activation. We investigated the role of the B7 family of costimulatory molecules in the development of the systemic maternal immune tolerance during healthy pregnancy (HP). The alterations contributing to maternal tolerance are present at the maternal-fetal interface, and at the systemic level. Several components of this pregnancy-specific immune tolerance have been described over the recent years [1]. One of the most important factors is the decreased level of activation of T cells compared to the non-pregnant state. Several other factors may account for the decreased level of peripheral T lymphocyte activation in healthy pregnancy (HP)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.